MedPath

Dipole Density Mapping of Typical Atrial Flutter

Not Applicable
Completed
Conditions
Atrial Flutter
Interventions
Device: Acutus Medical System Mapping
Registration Number
NCT01914497
Lead Sponsor
Acutus Medical
Brief Summary

Study to determine the feasibility of the Acutus Medical System in obtaining data to create Dipole Density Maps of electrical activation in the right atrium in patients with typical atrial flutter.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3
Inclusion Criteria
  1. Be aged 18 to 75 years
  2. Be scheduled for ablation of typical atrial flutter (cavotricuspid isthmus dependent)
  3. Be able and willing to give informed consent
Exclusion Criteria
  1. Have any of the following:

    1.1 Patients with implanted prosthetic, artificial, or repaired cardiac valves in the chamber being mapped.

    1.2 Patients with permanent pacemaker or ICD leads in the chamber being mapped. 1.3Patients with hypercoagulopathy or an inability to tolerate anticoagulation therapy during an electrophysiology procedure.

  2. Require treatment in the left atrium and/or a require a transseptal puncture to access the left atrium during the index procedure

  3. Have had a myocardial infarction within the prior two months

  4. Have had cardiac surgery within the prior three months

  5. Have an intracardiac thrombus

  6. Have clinically significant tricuspid valve regurgitation or stenosis

  7. Have had any cerebral ischemic event (including transient ischemic attacks) in the prior six months

  8. Be pregnant or nursing

  9. Be currently enrolled in any other clinical investigation

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Acutus Medical SystemAcutus Medical System MappingProprietary software algorithms will be used generate electrical activation maps based dipole density data acquired by the Acutus Medical Catheter during the procedures. These activation maps will then be applied to a 3D model of the endocardial surface to create a 3D activation map.
Primary Outcome Measures
NameTimeMethod
Incidence of device-and procedure-related adverse events7 days
The number of patients in which offline construction of pre- and post-treatment activation maps can be completed7 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Universitätsklinikum Hamburg-Eppendorf

🇩🇪

Hamburg, Germany

© Copyright 2025. All Rights Reserved by MedPath